| 000 | 00995 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517204239.0 | ||
| 264 | 0 | _c20190821 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1873-0183 | ||
| 024 | 7 |
_a10.1016/j.autrev.2018.03.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Heijden, E H M | |
| 245 | 0 | 0 |
_aOptimizing conventional DMARD therapy for Sjögren's syndrome. _h[electronic resource] |
| 260 |
_bAutoimmunity reviews _c05 2018 |
||
| 300 |
_a480-492 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aSjogren's Syndrome _xdrug therapy |
| 700 | 1 | _aKruize, A A | |
| 700 | 1 | _aRadstake, T R D J | |
| 700 | 1 | _avan Roon, J A G | |
| 773 | 0 |
_tAutoimmunity reviews _gvol. 17 _gno. 5 _gp. 480-492 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.autrev.2018.03.003 _zAvailable from publisher's website |
| 999 |
_c28166788 _d28166788 |
||